Morgan Stanley Generation Bio Co. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Generation Bio Co. stock. As of the latest transaction made, Morgan Stanley holds 941,782 shares of GBIO stock, worth $2.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

941,782

Previous 1,064,064 11.49%

Holding current value

$2.66 Million

Previous $1.76 Million 118.4%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.73 - $4.07 $211,547 - $497,687	-122,282 Reduced 11.49%	941,782 $3.83 Million
Q4 2023 Feb 13, 2024	BUY	$0.91 - $3.35 $510,595 - $1.88 Million	561,094 Added 111.56%	1,064,064 $1.76 Million
Q3 2023 Nov 15, 2023	SELL	$3.65 - $6.9 $77,569 - $146,638	-21,252 Reduced 4.05%	502,970 $1.91 Million
Q2 2023 Aug 14, 2023	BUY	$3.5 - $5.67 $36,498 - $59,126	10,428 Added 2.03%	524,222 $2.88 Million
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $78,762 - $152,944	21,818 Added 4.43%	513,794 $2.21 Million

Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $18,636 - $34,472	5,092 Added 1.05%	491,976 $1.93 Million
Q3 2022 Nov 14, 2022	BUY	$4.68 - $8.34 $1.32 Million - $2.36 Million	283,067 Added 138.88%	486,884 $2.59 Million
Q2 2022 Oct 27, 2022	SELL	$4.87 - $9.41 $46,420 - $89,696	-9,532 Reduced 4.47%	203,817 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$4.87 - $9.41 $46,420 - $89,696	-9,532 Reduced 4.47%	203,817 $1.34 Million
Q1 2022 Oct 27, 2022	BUY	$4.16 - $7.76 $39,653 - $73,968	9,532 Added 4.68%	213,349 $1.57 Million
Q1 2022 May 13, 2022	SELL	$4.16 - $7.76 $128,136 - $239,023	-30,802 Reduced 12.62%	213,349 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $44,056 - $183,654	7,355 Added 3.11%	244,151 $1.73 Million
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.43 $4.74 Million - $6.5 Million	236,796 New	236,796 $5.94 Million

Others Institutions Holding GBIO

# of Institutions

Shares Held

49.5M

Call Options Held

20.3K

Put Options Held

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $166M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account